B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC23A1

MOLECULAR TARGET

solute carrier family 23 member 1

UniProt: Q9UHI7NCBI Gene: 99632 compounds

SLC23A1 (solute carrier family 23 member 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC23A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Ascorbic Acid1.102
2Ascorbic Acid1.102

About SLC23A1 as a Drug Target

SLC23A1 (solute carrier family 23 member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented SLC23A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC23A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.